A Phase I, Multicenter, Dose Escalation Study of CAT-8015 in Participants with Chronic Leukemia

Trial Identifier: CAT-8015-1002
Sponsor: MedImmune, LLC
Collaborator:
Cambridge Antibody Technology
NCTID:: NCT00587457
Start Date: March 2007
Primary Completion Date: April 2008

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Poland Lodz, Poland
United States of America, CA Beverly Hills, CA, United States of America
United States of America, IN Indianapolis, IN, United States of America
United States of America, MD Bethesda, MD, United States of America